The strong allogeneic response to donor MHC molecules in transplantation and the weak response to tumor antigens represent two important and divergent but potentially interactive immune responses.

9 have identified a soluble specific antigen in 31 per cent of human ... us with clear-cut evidence of immunologic rejection of human cancer. This unique opportunity permitted the observation ...

In 1969, in a seminal manuscript entitled 'Immunological paradoxes: theoretical consideration in the rejection or retention ... end point (evaluation of tumor antigen-specific T cells) is not ...

Balancing the immune system is a delicate act. If it’s too weak, infections and cancer can take hold; if it’s too strong, autoimmune diseases or transplant rejection can occur. Researchers have ...

Researchers in China have used the body's own immune system to kill cancerous cells in a pioneering new therapy Scientists have turned the same immune response that rejects organ transplants to their ...